Anthralin
Anthralin
Definition
A natural anthraquinone derivative, anti-psoriatic and anti-inflammatory Anthralin (dithranol) controls skin growth by reducing DNA synthesis and mitotic activity in the hyperplastic epidermis, restoring a normal rate of cell proliferation and keratinization. Used topically in the treatment of psoriasis, dermatoses, and alopecia areata, it is also used in biomedical research due to its effect on EGFR autophosphorylation. (NCI04)
Also known as 1,8-Dihydroxy-9(10H)-anthracenone, ANTHRALIN — per NCIT
Also identified as
- ATC D05AC01 per RXNORM
- NCIT NCIT:C28827 per NCIT
- SCTID 387293003 per RXNORM
- SCTID 53800008 per RXNORM
- UNII U8CJK0JH5M per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Psoriasis | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Skin of body | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.